(Philadelphia, PA) – Grayson H. Wheatley, III, MD, FACS, Associate Professor of Surgery at Temple University School of Medicine, and Director of Aortic and Endovascular Surgery at Temple University Hospital, is serving as Conference Chairman for the International Society of Endovascular Specialists’ Mid-Atlantic Aortic Symposium on Saturday, September 27, in Philadelphia. The Symposium is being held from 8am-5pm at the Philadelphia Marriott Downtown.
Larry R. Kaiser, MD, FACS, Dean of Temple University School of Medicine, and President and CEO of Temple University Health System, will be a featured presenter at the event. Dr. Kaiser is an internationally renowned academic executive, thoracic surgeon, researcher and author, who will make a presentation entitled, “Managing Aortic Disease: The Health System Perspective.”
As Chairman of the Conference, Dr. Grayson Wheatley will give the welcome and opening remarks and will also serve as a presenter. Dr. Wheatley is an internationally-recognized leader in aortic surgery and endovascular therapies.
“I am pleased to be the Chairman of this exciting event,” says Dr. Wheatley. “The Symposium will bring together physicians, nurse practitioners, physician assistants, nurses, radiology technicians and cath lab personnel representing multiple specialties from across the Mid-Atlantic region to learn about the latest techniques and tools available for the management and treatment of aortic disease.”
Dr. Wheatley’s clinical and research interests include aortic and endovascular surgery; transcatheter valve replacement; minimally invasive cardiovascular surgery; physician education and training; innovative aortic therapies and endovascular technologies; and new techniques, quality and safety in endovascular interventions. His current research focuses on aortic stent-graft devices, investigations of autologous bone marrow cells in chronic limb ischemia, and embolic protection systems.
For more information on the Mid-Atlantic Aortic Symposium, visit https://www.isesonline.org/ises-mid-atlantic.html.
About Temple Health
Temple University Health System (TUHS) is a $1.4 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center; Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices. TUHS is affiliated with Temple University School of Medicine.
Temple University School of Medicine (TUSM), established in 1901, is one of the nation’s leading medical schools. Each year, the School of Medicine educates approximately 840 medical students and 140 graduate students. Based on its level of funding from the National Institutes of Health, Temple University School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania. According to U.S. News & World Report, TUSM is among the top 10 most applied-to medical schools in the nation.
Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by Temple University School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.
Jeremy Walter
Manager of Media Relations
Temple Health Communications
